{"nctId":"NCT03292146","briefTitle":"Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study","startDateStruct":{"date":"2017-10-25","type":"ACTUAL"},"conditions":["Bone Density","Bone Loss","Anorexia Nervosa","Eating Disorder","Atypical Anorexia Nervosa"],"count":30,"armGroups":[{"label":"Active Denosumab 60mg Injection","type":"EXPERIMENTAL","interventionNames":["Drug: Denosumab 60 MG [Prolia]","Drug: Alendronate 70Mg Tab"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo Injection","Drug: Alendronate 70Mg Tab"]}],"interventions":[{"name":"Denosumab 60 MG [Prolia]","otherNames":[]},{"name":"Placebo Injection","otherNames":[]},{"name":"Alendronate 70Mg Tab","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion/Exclusion Criteria:\n\nInclusion Criteria:\n\n* Female\n* Age 20-60 years, skeletally mature with closed epiphyses\n* Anorexia nervosa or atypical anorexia nervosa defined by DSM-V diagnostic criteria\n* BMD T-score \\< -1.0\n* Normal serum 25-OH vitamin D (\\>30 ng/mL) and calcium levels\n* For women of reproductive age, agree to use an effective contraceptive method. Highly effective methods of birth control include:\n\n  * Combined (estrogen and progestogen) hormonal methods (pills, vaginal ring, or skin patch)\n  * Intrauterine device (IUD)\n  * Intraduterine hormonal-releasing system (IUS)\n  * Surgery to tie both fallopian tubes (bilateral tubal ligation/occlusion)\n  * Your male partner has had a vasectomy and testing shows there is no sperm in the semen\n* Dental check up within the past year\n\nExclusion Criteria:\n\n* Any disease known to affect bone, including untreated thyroid dysfunction, Cushing's or renal failure\n* Subjects with a known esophageal disease cannot participate in the alendronate extension study\n* Any medication known to affect bone metabolism within 3 months of the study, excluding oral contraceptives or other forms of estrogen administration. Bisphosphonates must have been discontinued for at least one year before participation\n* Immunodeficiency or taking immunosuppressive therapy\n* Serum potassium \\<3.0 meq/L\n* Serum ALT \\>3 times upper limit of normal\n* eGFR of less than 30 ml/min\n* Hypocalcemia\n* Diabetes mellitus\n* Active substance abuse, including alcohol\n* History of malignancy\n* Paget disease of bone\n* Osteomalacia\n* Osteonecrosis of the jaw (ONJ) or risk factor for ONJ, such as invasive dental procedures (eg, tooth extraction, dental implants, oral surgery in the past 6 months), poor oral hygiene, periodontal and/or pre-existing dental disease, and current use of corticosteroids.\n* Planned invasive dental procedure over the next 24 months.\n* Known senstivity to any of the products or components to be administered during dosing or known sensitivity to mammalian cell derived drug products\n* Sensitivity to calcium or vitamin D supplements\n* Pregnant, planning to become pregnant with 7 months after the end of treatment and/or breastfeeding","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"20 Years","maximumAge":"60 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Postero-anterior (PA) Lumbar Spine Bone Mineral Density by Dual-energy X-ray Absorptiometry (DXA)","description":"Postero-anterior (PA) lumbar spine bone mineral density was assessed by dual-energy x-ray absorptiometry (DXA). The DXA scanner used was a Hologic Horizon A (Hologic, Inc., Waltham, MA).","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.90","spread":"0.03"},{"groupId":"OG001","value":"0.87","spread":"0.04"}]}]}]},{"type":"SECONDARY","title":"Percent Change Postero-anterior (PA) Lumbar Spine Bone Mineral Density by DXA","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.9","spread":"4.3"},{"groupId":"OG001","value":"5.8","spread":"5.3"}]}]}]},{"type":"SECONDARY","title":"Percent Change Postero-anterior (PA) Lumbar Spine Bone Mineral Density by DXA","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.0","spread":"3.7"},{"groupId":"OG001","value":"4.6","spread":"3.2"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":20},"commonTop":["constipation","COVID-19","bone fracture","nausea/stomach pain/bloating","Keratitis"]}}}